Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 8/2022

09.02.2022 | Original Article

Mid-term results of mitral valve reconstruction with autologous pericardial patch for active infective endocarditis with extensive leaflet destruction

verfasst von: Ryoji Kinoshita, Hirokuni Arai, Masafumi Yashima, Tsuyoshi Hachimaru, Tatsuki Fujiwara, Kiyoshi Tamura, Hiroyuki Tanaka, Keiji Oi, Tomohiro Mizuno, Eiki Nagaoka

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aimed to evaluate the outcomes of our repair technique using autologous pericardial patches for active infective endocarditis with extensive mitral valve destruction.

Methods

From 2009 through 2016, 12 patients with extensive mitral leaflet destruction due to infective endocarditis underwent mitral valve repair with an autologous pericardial patch. Mid-term clinical outcomes and echocardiographic findings of these patients were retrospectively assessed.

Results

The perioperative mortality rate was 8.3% (1/12). Postoperatively, the mitral regurgitation grade was ≤ 1 + in all patients. During 5.0 ± 3.2 years of follow-up, there was no recurrence of infective endocarditis or death. There were no cases of mitral regurgitation grade >  + 1 and pressure gradient > 5 mmHg during follow-up among 6 patients who underwent posterior leaflet reconstruction, whereas elevation of the pressure gradient was observed in patients who underwent reconstruction of two areas of the anterior leaflet and survived up till the follow-up phase among 3 patients who underwent anterior leaflet repair. The mitral regurgitation grade worsened and pressure gradient was elevated during the follow-up phase in the 2 patients who underwent bi-leaflet repair, and reoperation was performed.

Conclusion

Mitral valve reconstruction using autologous pericardial patch is a useful treatment option for extensive mitral valve destruction due to active infective endocarditis. Our clinical data revealed that good mid-term results were obtained for posterior leaflet lesions, while extensive anterior leaflet and bi-leaflet lesion repair did not yield satisfactory results. The indication for surgical repair should be carefully evaluated when an extensive anterior region is involved.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318–30.CrossRef Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318–30.CrossRef
2.
Zurück zum Zitat Bernard D, Tornos P. Surgery for infective endocarditis who and when? Circulation. 2010;121:1141–52.CrossRef Bernard D, Tornos P. Surgery for infective endocarditis who and when? Circulation. 2010;121:1141–52.CrossRef
3.
Zurück zum Zitat Doukas G, Oc M, Alexiou C, Sosnowski AW, Samani NJ, Spyt TJ. Mitral valve repair for active culture-positive infective endocarditis. Heart. 2006;92:361–3.CrossRef Doukas G, Oc M, Alexiou C, Sosnowski AW, Samani NJ, Spyt TJ. Mitral valve repair for active culture-positive infective endocarditis. Heart. 2006;92:361–3.CrossRef
4.
Zurück zum Zitat Cuerpo GP, Valerio M, Pedraz A, Rodríguez-Abella H, Mestres CA, Obrador EQ, et al. Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry. Gen Thorac Cardiovasc Surg. 2019;67:585–93.CrossRef Cuerpo GP, Valerio M, Pedraz A, Rodríguez-Abella H, Mestres CA, Obrador EQ, et al. Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry. Gen Thorac Cardiovasc Surg. 2019;67:585–93.CrossRef
5.
Zurück zum Zitat Zegdi R, Debièche M, Latrémouille C, Lebied D, Chardigny C, Grinda JM, et al. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.CrossRef Zegdi R, Debièche M, Latrémouille C, Lebied D, Chardigny C, Grinda JM, et al. Long-term results of mitral valve repair in active endocarditis. Circulation. 2005;111:2532–6.CrossRef
6.
Zurück zum Zitat Eric S, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M, et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg. 2009;87:1728–34.CrossRef Eric S, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M, et al. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg. 2009;87:1728–34.CrossRef
7.
Zurück zum Zitat Harky A, Hof A, Garner M, Froghi S, Bashir M. Mitral valve repair or replacement in native valve endocarditis? Systematic review and meta-analysis. J Card Surg. 2018;33:364–71.CrossRef Harky A, Hof A, Garner M, Froghi S, Bashir M. Mitral valve repair or replacement in native valve endocarditis? Systematic review and meta-analysis. J Card Surg. 2018;33:364–71.CrossRef
8.
Zurück zum Zitat Elfriede R, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005;130:765–71.CrossRef Elfriede R, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005;130:765–71.CrossRef
9.
Zurück zum Zitat Sheikh AM, Elhenawy AM, Maganti M, Armstrong S, David TE, Feindel CM. Outcomes of surgical intervention for isolated active mitral valve endocarditis. J Thorac Cardiovasc Surg. 2009;137:110–6.CrossRef Sheikh AM, Elhenawy AM, Maganti M, Armstrong S, David TE, Feindel CM. Outcomes of surgical intervention for isolated active mitral valve endocarditis. J Thorac Cardiovasc Surg. 2009;137:110–6.CrossRef
10.
Zurück zum Zitat Carpentier A. Cardiac valve surgery–the “French correction.” J Thorac Cardiovasc Surg. 1983;86:323–37.CrossRef Carpentier A. Cardiac valve surgery–the “French correction.” J Thorac Cardiovasc Surg. 1983;86:323–37.CrossRef
11.
Zurück zum Zitat Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721–8.CrossRef Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007;115:1721–8.CrossRef
12.
Zurück zum Zitat Nakatani S, Mitsutake K, Ohara T, Kokubo Y, Yamamoto H, Hanai S, et al. Recent picture of infective endocarditis in Japan-lessons from Cardiac Disease Registration (CADRE-IE). Circ J. 2013;77:1558–64.CrossRef Nakatani S, Mitsutake K, Ohara T, Kokubo Y, Yamamoto H, Hanai S, et al. Recent picture of infective endocarditis in Japan-lessons from Cardiac Disease Registration (CADRE-IE). Circ J. 2013;77:1558–64.CrossRef
13.
Zurück zum Zitat Evans CF, DeFilippi CR, Shang E, Griffith BP, Gammie JS. Fresh autologous pericardium for leaflet perforation repair in mitral valve infective endocarditis. J Heart Valve Dis. 2013;22:560–6.PubMed Evans CF, DeFilippi CR, Shang E, Griffith BP, Gammie JS. Fresh autologous pericardium for leaflet perforation repair in mitral valve infective endocarditis. J Heart Valve Dis. 2013;22:560–6.PubMed
14.
Zurück zum Zitat Ushijima T, Kikuchi Y, Takata M, Yamamoto Y, Kawachi K, Watanabe G. Commissural autologous pericardial patch repair: A novel technique for active mitral valve endocarditis involving the mitral annulus. Ann Thorac Surg. 2009;88:e29-30.CrossRef Ushijima T, Kikuchi Y, Takata M, Yamamoto Y, Kawachi K, Watanabe G. Commissural autologous pericardial patch repair: A novel technique for active mitral valve endocarditis involving the mitral annulus. Ann Thorac Surg. 2009;88:e29-30.CrossRef
15.
Zurück zum Zitat Takahashi H, Kadowaki T, Maruo A, Yutaka O, Oshima Y. Mid-term results of mitral valve repair with autologous pericardium in pediatric patients. J Heart Valve Dis. 2014;23:302–9.PubMed Takahashi H, Kadowaki T, Maruo A, Yutaka O, Oshima Y. Mid-term results of mitral valve repair with autologous pericardium in pediatric patients. J Heart Valve Dis. 2014;23:302–9.PubMed
16.
Zurück zum Zitat Shomura Y, Okada Y, Nasu M, Koyama T, Yuzaki M, Murashita T, et al. Late results of mitral valve repair with glutaraldehyde-treated autologous pericardium. Ann Thorac Surg. 2013;95:2000–6.CrossRef Shomura Y, Okada Y, Nasu M, Koyama T, Yuzaki M, Murashita T, et al. Late results of mitral valve repair with glutaraldehyde-treated autologous pericardium. Ann Thorac Surg. 2013;95:2000–6.CrossRef
17.
Zurück zum Zitat Fukunaga N, Matsuo T, Saji Y, Imai Y, Koyama T. Mitral valve stenosis progression due to severe calcification on glutaraldehyde-treated autologous pericardium: Word of caution for an attractive repair technique. Ann Thorac Surg. 2015;99:2203–5.CrossRef Fukunaga N, Matsuo T, Saji Y, Imai Y, Koyama T. Mitral valve stenosis progression due to severe calcification on glutaraldehyde-treated autologous pericardium: Word of caution for an attractive repair technique. Ann Thorac Surg. 2015;99:2203–5.CrossRef
18.
Zurück zum Zitat Ito T, Maekawa A, Sawaki S, Fujii G, Hoshino S, Hayashi Y. Reconstruction of mitral valve chordae and leaflets with one piece of autologous pericardium in extensively destructed mitral valve due to active infective endocarditis. Gen Thorac Cardiovasc Surg. 2013;61:571–3.CrossRef Ito T, Maekawa A, Sawaki S, Fujii G, Hoshino S, Hayashi Y. Reconstruction of mitral valve chordae and leaflets with one piece of autologous pericardium in extensively destructed mitral valve due to active infective endocarditis. Gen Thorac Cardiovasc Surg. 2013;61:571–3.CrossRef
Metadaten
Titel
Mid-term results of mitral valve reconstruction with autologous pericardial patch for active infective endocarditis with extensive leaflet destruction
verfasst von
Ryoji Kinoshita
Hirokuni Arai
Masafumi Yashima
Tsuyoshi Hachimaru
Tatsuki Fujiwara
Kiyoshi Tamura
Hiroyuki Tanaka
Keiji Oi
Tomohiro Mizuno
Eiki Nagaoka
Publikationsdatum
09.02.2022
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 8/2022
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-022-01776-9

Weitere Artikel der Ausgabe 8/2022

General Thoracic and Cardiovascular Surgery 8/2022 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.